CGON
CG OncologyDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
CGON vs peer average
34/100
CGON vs. peer average (D vs. C)
Grade spread
A 1 · B 1 · C 4 · D 1 · F 1
Graded peers loaded
Coverage
8 graded
89% of tracked
Peer overview
FGEN is the first available peer comparator.
Company with targeted oncology assets and partnership-driven upside potential; comparable commercialization uncertainty.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CGON
CG Oncology
FGEN
Peer
Grade
D
-
Momentum
27
-
Value
41
-
Sentiment
63
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Unrated
Grade position vs FGEN
CGON / FGEN
Grade Position
Below peers
CGON vs. peer average (D vs. C)
34/100
Momentum
27
-Value
41
-Sentiment
63
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CGON
FGEN is the first peer returned for this comparison set.